Related Experiment Video
Updated: Mar 22, 2026

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
Published on: November 2, 2017
RNF4-mediated SUMOylation is essential for NDRG2 suppression of lung adenocarcinoma
Jicheng Tantai1, Xufeng Pan1, Dingzhong Hu1
1Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Abstract:
N-Myc downstream-regulated gene 2 (NDRG2) protein is a tumor suppressor that inhibits cancer growth, metastasis and invasion. The ubiquitin ligase RNF4 integrates signaling by SUMO and ubiquitin through its selective recognition and ubiquitination of SUMO-modified proteins. We evaluated NDRG2 SUMOylation in lung adenocarcinoma cells and its underlying molecular mechanism. The results showed that NDRG2 is covalently modified by SUMO1 at K333, which suppressed anchorage independent adenocarcinoma cell proliferation and tumor growth. In human lung adenocarcinomas cells, RNF4 targeted NDRG2 to proteasomal degradation by stimulating its SUMOylation. Endogenous RNF4 expression was increased in human lung adenocarcinomas cells, and there was a concomitant upregulation of SUMO. These findings indicate that SUMOylation of NDRG2 is necessary for its tumor suppressor function in lung adenocarcinoma and that RNF4 increases the efficiency of this process.
Insights
N-Myc downstream-regulated gene 2 (NDRG2) protein suppresses tumors. SUMOylation of NDRG2 at K333 inhibits lung adenocarcinoma cell proliferation. RNF4 targets SUMOylated NDRG2 for degradation, enhancing its tumor suppressor function.
Area of Science:
- Molecular biology
- Cancer research
- Biochemistry
Background:
- N-Myc downstream-regulated gene 2 (NDRG2) functions as a tumor suppressor, inhibiting cancer progression.
- The ubiquitin ligase RNF4 mediates signaling by SUMO and ubiquitin through SUMO-modified proteins.
- Understanding NDRG2 SUMOylation is crucial for cancer therapy.
Purpose of the Study:
- To investigate the SUMOylation of NDRG2 in lung adenocarcinoma cells.
- To elucidate the molecular mechanism underlying NDRG2 SUMOylation.
- To determine the role of RNF4 in NDRG2 regulation.
Main Methods:
- SUMOylation assays in lung adenocarcinoma cells.
- Identification of SUMOylation sites on NDRG2.
- Analysis of RNF4 expression and its effect on NDRG2.
- Proteasomal degradation assays.
Main Results:
- NDRG2 undergoes SUMO1 modification at lysine 333 (K333).
- SUMOylation of NDRG2 at K333 suppresses anchorage-independent proliferation and tumor growth.
- RNF4 promotes the SUMOylation-dependent proteasomal degradation of NDRG2.
- Increased RNF4 and SUMO expression observed in human lung adenocarcinomas.
Conclusions:
- NDRG2 SUMOylation is essential for its tumor suppressor activity in lung adenocarcinoma.
- RNF4 enhances NDRG2 tumor suppression by promoting its SUMOylation and degradation.
- Targeting the NDRG2-RNF4-SUMO pathway may offer therapeutic strategies for lung adenocarcinoma.
Related Concept Videos
Abnormal Proliferation
Regulation of Nuclear Protein Sorting
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
MicroRNAs
NF-kB-dependent Signaling Pathway
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

